Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6970069 | 0.85 | MEN1 (0.32) | MEN1MAPTHTTKMT2A | |
| SCHEMBL17998022 | 0.77 | — | — | |
| SCHEMBL10212111 | 0.77 | — | — | |
| SCHEMBL73292 | 0.74 | — | — | |
| SCHEMBL1437045 | 0.73 | MEN1 (0.39) | MEN1MAPTHTTKMT2A | |
| SCHEMBL9951972 | 0.69 | MEN1 (0.31) | MEN1MAPTHTTKMT2A | |
| SCHEMBL20034064 | 0.67 | — | — | |
| SCHEMBL12112190 | 0.67 | MEN1 (0.31) | MEN1MAPTHTTKMT2A | |
| SCHEMBL13990717 | 0.67 | — | — | |
| SCHEMBL13617319 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11158810-B2 | Polycyclic compound and organic light emitting device comprising same | LG CHEM, LTD. | 2021-10-26 | — | — | US | disclosed |
| US-20200127207-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| US-20170204134-A1 | Cyclising Peptides | THE UNIVERSITY OF DURHAM (GB) | 2017-07-20 | — | — | US | disclosed |
| US-7432379-B2 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7417152-B2 | 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases | ELAN PHARMACEUTICALS, INC. (US) | 2008-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11158810-B2 | Polycyclic compound and organic light emitting device comprising same | CRY1, CYP1A1, CYP1B1 | MEN1 190/4885MAPT 1695/4885HTT 3869/4885 |
| US-20200127207-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | MEN1 190/4885MAPT 1695/4885HTT 3869/4885 |
| US-20170204134-A1 | Cyclising Peptides | VIP, NGLY1, NPPA | MEN1 151/4885MAPT 4290/4885HTT 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.